跳至主要内容
临床试验/NCT06598566
NCT06598566已完成不适用

A Comparative Evaluation of Nottingham Hip Fracture Score (NHFS) and Acute Physiology and Chronic Health Evaluation (APACHE) II Score to Predict 30-day Mortality in Geriatric Patients Above 60 Years Undergoing Hip Fracture Surgery.

Tata Main Hospital1 个研究点 分布在 1 个国家目标入组 182 人开始时间: 2022年6月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
182
试验地点
1
主要终点
Mortality

研究概览

简要总结

This study aims to compare the Nottingham Hip Fracture Score (NHFS) and the Acute Physiology and Chronic Health Evaluation II (APACHE II) score in predicting 30-day mortality in geriatric patients over 60 years old undergoing hip fracture surgery.

详细描述

The study aim to compare the Nottingham Hip Fracture Score (NHFS) and the Acute Physiology and Chronic Health Evaluation II (APACHE II) score in predicting 30-day mortality in geriatric patients over 60 years undergoing hip fracture surgery. This study was conducted at the Tata Main Hospital in Jamshedpur, India. The study was designed as a prospective observational study, with data collected from June 2022 to June 2023. The study's primary objective was to predict mortality in patients undergoing hip fracture surgery. The study also investigated secondary outcomes such as the need for postoperative ventilator and ionotropic support, the occurrence of acute kidney injury, cardiac morbidity, and the presence of pulmonary embolism and deep vein thrombosis, as well as length of stay.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age more than or equal to 60 years, Underwent Hip fracture surgeries, of Either Sex

排除标准

  • Age less than 60 years of age, Hip fractures not undergoing any invasive surgery, Implant removals planned for healed hip fractures, Re-explorations during the same admission in which primary surgery was conducted

结局指标

主要结局

Mortality

时间窗: 30 days

Mortality at least 30 days after surgery or death (during hospital stay or within 30 days after surgery.

次要结局

  • Length of Stay (LOS)(30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr.Deb Sanjay Nag

HOD & Head Consultant, Anaesthesiology

Tata Main Hospital

研究点 (1)

Loading locations...

相似试验